Aldosterone receptor blockers spironolactone and canrenone: Two multivalent drugs

Expert Opinion on Pharmacotherapy

Volumn 15, Issue 7, 2014, Pages 909-912

  Armanini, Decio ^a   Sabbadin, Chiara ^a   Donà, Gabriella ^a   Clari, Giulio ^a   Bordin, Luciana ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aldosterone; Canrenone; Inflammation; Microalbuminuria; Spironolactone

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CANRENONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; HYDROCHLOROTHIAZIDE; MINERALOCORTICOID RECEPTOR; POTASSIUM; SPIRONOLACTONE;

DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POTASSIUM BLOOD LEVEL; REVIEW; SURVIVAL RATE;

ALBUMINURIA; ALDOSTERONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CANRENONE; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; SPIRONOLACTONE;

EID: 84899440076     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2014.896901     Document Type: Review

References (17)

1. Doggrell SA, Brown L. The spironolactone renaissance. Expert Opin Investig Drugs 2001;10(5):943-54
2. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 2004;217:53-8
3. De Simone G, Chinali M, Mureddu GF, et al. Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study. Nutr Metab Cardiovasc Dis 2011;21(10):783-91
4. Ouzounian M, Hassan A, Cox JL, et al. The effect of spironolactone use on heart failure mortality: a population-based study. J Card Fail 2007;13(3):165-9
5. Derosa G, Bonaventura A, Bianchi L, et al. Effects of canrenone in patients with metabolic syndrome. Expert Opin Pharmacother 2013;14(16):2161-9
6. Armanini D, Castello R, Scaroni C, et al. Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol 2007;131(1):61-7
7. Armanini D, Bordin L, Donà G, et al. Polycystic ovary syndrome: implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids 2012;77(6):655-8
8. Armanini D, Karbowiak I, Goi A, et al. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay. Clin Endocrinol (Oxf) 1985;23:341-7
9. Andriulli A, Arrigoni A, Gindro T, et al. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy. Digestion 1989;44(3):155-62
10. Bordin L, Donà G, Sabbadin C, et al. Human red blood cells alterations in primary aldosteronism. J Clin Endocrinol Metab 2013;98(6):2494-501
11. Schjoedt KJ, Andersen S, Rossing P, et al. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nefropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 2004;47:1936-9
12. Fogari R, Derosa G, Zoppi A, et al. Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria. Expert Opin Pharmacother 2014;15(4):453-9
13. Ma J, Albornoz F, Yu Chang et al. Differing effects of mineralocorticoid receptor-dependent and-independent potassium-sparing diuretics on fibrinolytic balance. Hypertension 2005;46:313-20
14. Armanini D, Strasser T, Weber PC. Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol 1985;248:E388-90
15. Calò LA, Zaghetto F, Pagnin E, et al. Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes. J Clin Endocrinol Metab 2004;89:1973-6
16. Fiore C, Sartorato P, Pagnin E, et al. Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro. J Endocrinol Invest 2009;32:895-8
17. Seley H. Anticortisol action of aldosterone. Science 1955;121:368-9